VHT ETF Vanguard Health Care Index Fund ETF Shares

$326.69
1d-0.4%5d-6.1%1m-1.67%ytd+13.49%
At close · Nov 20, 4:00 PM ET
After hours $326.99 +0.09% · Nov 20, 6:13 PM ET
52w low $264.9769% of range$354.83 52w high
Price

Today’s call · VHT

All live ideas →

4 of 6 technical checks lean bearish

VHT is turning up, momentum soft. $328.38 is the level overhead; $325 the first support below.

No open idea.From $326.69 the reward-to-risk to $328.38 against $325 is 1 — below the 3:1 bar.
What would create one:
  • A close above $328.38 on rising volume (breakout).
  • A pullback to $325 that holds (entry near support).
Alert me at a level

The brief

Price vs 50-day · belowPrice vs 200-day · above50d vs 200d avg · aboveMACD · bearishRSI momentum · 395-day tape · -6.1%
levelPrice is 0.52% from resistance $328.38 — watch for a break or rejection.
levelFirst support $325.0 is 0.52% below.
signalVHT’s 50-day average is above the 200-day — long-term trend alignment is bullish.
All readings
TrendTurning up · below 50-day & 200-day
MomentumRSI 39.2 · MACD bearish
Trend strengthADX 30.9 · strong trend
Location-0.5% vs 50-day MA
52-week range-7% from high · +23% from low
VolatilityATR 7.03 · ~2.2%/day
RSI 14
39.2
MACD
1.56
ADX 14
30.9
ATR 14
7.03
SMA 50
$328.38
SMA 200
$300.2

Levels that matter

$328.38sma 50+0.5%
$330.2swing zone · 2×+1.1%
$350round+7.1%
$325round−0.5%
$309.53swing zone · 4×−5.3%
$300.2sma 200−8.1%

Compare with…

Analyst overview · Nov 21

Vanguard Health Care ETF (VHT) poised for short‑term upside

VHT slipped to $326.69 on Friday, extending a five‑day pullback that left it 7% below its recent high of $351.23. The move occurred inside a weekly uptrend that remains intact, with price still above its 40‑week average and the ETF outperforming the S&P 500 by 9.5% over the past 50 days. The balance of evidence points to a modest upside in the next two to six weeks, provided the next daily close clears the 50‑day moving average on stronger‑than‑average volume.

Why it matters

The ETF’s recent weakness was driven largely by a broad rotation out of health‑care exposure rather than any specific holding. The 5‑day performance gap – VHT down 6.1% versus the S&P 500’s 8.6% decline – shows the basket fell less than the market, underscoring its defensive tilt. The pullback also coincided with a 18.4% drop in volume relative to the 20‑day average, suggesting limited conviction behind the sell‑off.

Market participants had already priced in a modest correction after the ETF’s November 4 peak. The price now sits 7% below that high and 23% above the 52‑week low, leaving ample room for a bounce if buying pressure returns. The weekly trend remains bullish, as the price stays above the 40‑week average and the 50‑day simple moving average ($328.38) still acts as the nearest resistance.

Debate around VHT centers on two points. One side argues that the pullback has pushed the RSI to 39, a level often interpreted as oversold, and that the ETF’s outperformance versus the S&P 500 signals a durable defensive premium. The opposite view cautions that the volume contraction and the ETF’s failure to break the 50‑day average on higher volume keep the upside constrained, and that a further slip toward the 200‑week average ($300.2) could erode the weekly trend.

No specific news item explained the move; the market reaction appears to be a technical correction rather than a fundamental shift in the health‑care sector. Analyst price targets are not available, so valuation comparison is omitted.

What the evidence says

Long‑term, the thesis that health‑care remains a resilient, income‑generating theme is intact. The ETF is still above its 40‑week average, the 200‑week average ($300.2) remains well below current levels, and the 52‑week range shows a 23% upside from the low. The weekly trend is therefore still in an up phase, and the pullback is a typical retracement within that trend.

Looking ahead 2‑6 weeks, the balance of evidence leans positive but with medium conviction. Two of four conviction points are met: the pullback sits in oversold territory and the ETF is leading the S&P 500 over the past 50 days (+9.5%). The breakout math calls for a daily close above $328.38 on volume above the 20‑day average; a stop sits at $323.24, giving a modest reward‑to‑risk of 0.4 to the first target of $330.2. The lack of a 3‑to‑1 reward‑to‑risk ratio keeps conviction from being higher.

The strongest case against a near‑term upside is the weak volume profile – volume is 18.4% below its 20‑day average – and the price is still below the 50‑day moving average, a key technical barrier. Even if the price clears $328.38, the modest ATR of $7.03 means a breakout could be short‑lived without a clear volume surge.

Levels that matter

The structure holds above $325, a round‑number support that also marks the first crack point in the price pattern. Below $300.2 – the 200‑week average – the weekly trend would be considered ended, as that level has historically acted as a long‑term floor for the ETF.

The breakout level is a close above $328.38, the 50‑day simple moving average, on volume exceeding the 20‑day average. If that occurs, the math projects a target at $330.2, derived from the swing‑zone pattern, with a reward‑to‑risk of 0.4. Because the trade does not meet a 3‑to‑1 payoff, a price move to roughly $335 would be needed to achieve that risk‑reward threshold.

What would change the picture

A weekly close below $300.2, the 200‑week average, would signal the weekly trend’s end and could shift the balance of evidence toward a negative short‑term outlook. The non‑price catalyst that could trigger such a move would be a sudden deterioration in health‑care policy – for example, a major regulatory setback that depresses the sector’s earnings outlook.

What to watch

  • Upcoming macro releases: the U.S. CPI report (mid‑December) and the Federal Reserve’s policy decision (late December) – both can swing risk sentiment and affect defensive ETFs.
  • Sector earnings: the quarterly results of the ETF’s largest holdings (e.g., UnitedHealth Group, Pfizer) scheduled throughout December and January.
  • Flow data: any notable net inflows or outflows into VHT reported by fund‑flow trackers.
  • Broad‑market technical trigger: a daily close above $328.38 on volume above the 20‑day average, which would validate the breakout math.

MarketCrew is AI-powered and can make mistakes — double-check before acting. Informational only, not investment advice.